 |
 |
| Cell therapy enabling safe haploidentical haematopoietic stem cell transplantation (HSCT) for the treatment of haematological malignancies. Phase III in high-risk acute leukaemia started in Italy |
 |
|
 |
 |
A novel VTA for vascularised solid tumours. Phase II trials as single agent ongoing in colorectal and liver cancer, and in mesothelioma. Phase II trials in combination ongoing with Xelox in colorectal cancer, with doxorubicin in small-cell lung and ovarian cancer, and with platinum-based regimens in non-small-cell lung cancer
|
 |
|
|
